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Abstract 
The infusion of intravenous immunoglobulin therapy in the home setting requires a 
critical nursing assessment and interventions  aimed at managing and preventing the 
escalation of adverse events. Some patients experience side effects that necessitate a 
rapid response by field nurses, requiring standing orders for nursing administration and 
the availability of essential medications to alleviate symptoms in the patient’s home. The 
clinical practice issue was that the home health agency did not have a uniform clinical 
practice nursing guideline to assist field nurses in providing rapid responses for managing 
infusion-related reactions. The purpose of this project was to develop an evidence-based 
clinical practice guideline   using standing orders for the comprehensive management of 
immunoglobulin side effects in the patient’s home. The practice-focused question 
centered on whether the use of a nursing practice guideline based on interprofessional 
collaboration could manage the side effects of patients in the home by decreasing the use 
of emergent care and improved quality of care   for those patients susceptible to 
significant side effects. An interdisciplinary expert panel experience in IVIG l used 
Newman’s system theory and the reach, effectiveness, adoption, implementation, 
maintenance framework for interprofessional collaboration in developing a clinical 
nursing guideline with a standing order for rating side effects. Panelists used the appraisal 
of guidelines, research, and evaluation II tool to appraise evidence for the guideline. The 
use of clinical guideline with standing orders to address the needs of patients in the home 
setting may lead to positive social change by enabling more rapid management of 
symptoms, more effective care in the home, and improved patient outcomes. 
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Section 1: Nature of the Project 
Introduction 
The home infusion of immunoglobulin therapy (IVIG) for the management of 
patients with autoimmune and other immune-related diseases has been in use since the 
early 1990s (Johnston & Hollingsworth, 2016). In the first years of IVIG use in the 
1990s, only a small number of patients received the treatment, resulting in limited 
variation in patients and side effects reported. Limitations in patient variation gave the 
overall sense of minimal side effects, which researchers classified as transient side effects 
(Berger, McCallum, & Lin, 2013). Medical researchers at that time did not see the need 
to develop a formal guideline to assist in uniform side effect management but rather 
performed individual research to prove the effectiveness of specific side effect 
management. However, clinical advances in biotechnology science now indicate other 
uses for IVIG, which has made it available for a wider range of disease treatment and 
management  such as Myasthenia Gravis, Chronic Demyelinating polyneuropathy, 
Guillain Barre Syndrome, primary immunodeficiency disease, and polyneuropathy to 
mention a few (Bonila, 2014).  
The increase in demand and use of IVIG has also come with a reported rise in 
documented side effects among patients using the product (Thornby, Henneman, & 
Brown, 2015). Some of the reasons postulated as causing the side effects are associated 
with patient comorbidity, antigen-antibody effects, and familial history (Berger et al., 
2013). The most common clinically documented side effects associated with IVIG are 
headaches, migraine, nausea and vomiting, thrombosis, elevated blood pressure, aplastic 
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meningitis, leg cramps, diarrhea, and rashes (Oaklander et al., 2017). Johnston and 
Hollingsworth (2016) noted that one third of patients receiving immune therapy have 
some documented side effects that require intervention both during and up to 48 hours 
post-infusion. The existing clinical guidelines and recommendations by specialty 
pharmacists and manufacturers for nurses when managing patients receiving home IVIG 
involve monitoring and assessing patients, noting any side effects, and understanding 
when to report side effects to physicians for further instruction and care (Vokey, 2013).  
Although current field nursing interventions include assessing and documenting 
side effects experienced by patients and notifying ordering physicians of patients’ 
experiences, they do not  fully incorporate the knowledge available to nurses from 
evidence-based research articles. The limited use of evidence-based interventions lends 
credence to the criticism of nurses as passive observers in the health care system noted by 
the Institute of Medicine Report (IOM; 2010). Overcoming obstacles such as these 
requires policy influence by nurse leaders to put evidence into practice to provide high-
quality care that improves patient outcomes and experiences through the provision of 
quick and rapid access to healthcare (Rose, Adams, & Johnson, 2016). Notifying the 
physician of the problems experienced by patients during infusion is only a part of the 
intervention because the physicians must, in turn, call in medications to a local pharmacy. 
These medications must then be picked up by already stressed caregivers or patients.  
Amplifying the problem is the fact that most local pharmacies, unlike specialty 
pharmacies, do not carry the rapid response medications needed to manage the side 
effects of IVIG in their formulary ( Bradford & Schulman,(2014). The only option 
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available to patients in this situation is the use of emergent care. In addition, field nurses 
are paid only for infusion and cannot wait indefinitely with patients for medication to be 
processed by the local pharmacy. All these factors prolong care delivery long after the 
nurse has terminated the infusion and left the patient’s house. The result is an increase in 
emergent care visits as the home health agency  patients  seek relief from their side 
effects increasing cost of care and decreasing quality of patient care (McKinney,  2010). 
Although the cost associated with symptom management in the emergent care setting has 
not been fully researched because of a lack of association with diagnosis codes ( Center 
for Medicare  (C.M.S,2018), there is evidence showing that the use of emergent care can 
be avoided if a systematic approach and interprofessional collaboration for improved 
patient care are a part of the intervention process of care. Research studies have indicated 
that attention should be on high quality, lowered costs, and the removal of redundancy 
(Oberlander, 2016). The control of health care costs can increase access to health care 
and improve quality of care and should be part of patient management, according to 
Rosenbaum and Thorpe (2016), who noted that improvements in patient care were the 
basis for the establishment of the Affordable Care Act. Decreasing fragmentation can be 
a way to reduce health care costs (McKinney, 2010). 
Research nurses must take an active role in leading change to address the issue of 
IVIG side effects and control the increased use of emergent care to manage side effects 
and other medical problems (IOM,2010). Leading change requires leadership through the 
use of evidence-based practices to influence policy (IOM,2010). The evidence-based 
practice must be grounded in research that targets patient and improves their health 
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outcomes as a metaparadigm of the nursing profession (McEwen & Wills, 2014). The 
role of the Doctor of Nursing Practice (DNP) student is to use education and knowledge 
gained in improving and promoting the use of the evidence-based practice in the clinical 
setting (Michael & Clochesy, 2016).   
As noted in the evidence-based literature, there are interventions that can be 
implemented to alleviate patients’ IVIG symptoms and improve outcomes (Canadian 
Agency for Drugs and Technologies in Health [CADTH], 2011). These interventions 
involve using a system of rapid response for the management of side effects in the home 
setting (CADTH, 2011). The system development should be done through a uniform 
standing order developed and approved through the interprofessional collaboration of 
nurses, physicians, and specialty pharmacy to ensure delivery of essential medications to 
the patient’s home for availability to field nurses when the need arises to enable rapid 
response intervention of patients in need (CADTH,2011). Research studies have shown 
that symptom management requires making available rapid response medications in the 
patient’s home (CADTH,2011)). The choice of essential medications to be delivered to 
patients’ home is determined after the patient’s history and physicals have been assessed 
(CADTH,2011). This must be done in addition to ensuring that patients have a good 
phone line and quick access to the home health agency and activation of emergent care 
(CADTH, 2011). The collaborative development and implementation of a clinical nursing 
practice guideline to address the management of side effects experienced by patients 
during and after infusion may improve patient outcomes, decrease emergent care visits, 
and improve the quality of care provided to patients.  
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Problem Statement 
The local home health agency did not have a uniform clinical practice nursing 
guideline with standing orders to assist field nurses in providing rapid responses for 
managing infusion-related reactions if not ordered by the attending physicians in the 
patient’s home. Not using evidence-based research in managing side effects of IVIG has 
resulted in a gap in nursing practice in that nurses are not able to respond rapidly to 
changes in the patient’s condition. This gap in clinical care requires research on the use of 
an interdisciplinary standing order by the local agency that is based on evidence-based 
research and that anticipates side effects from IVIG. Research is also needed on available 
interventions to guide field nurses in rapid response intervention for the management of 
side effects during and after infusion in a patient’s home. 
An analysis of evidence-based articles shows that anticipating the needs of the 
patient by reviewing his or her past medical history can reduce side effects by making 
essential medications available in the patient’s home for use (CADTH, 2011). 
Researchers such as Bonilla (2014) have noted that recommendations on managing the 
side effects of patients with a history of migraines should anticipate that these 
populations are more likely to have more headaches during infusion. One study indicated 
that thrombolytic events and pressure in the spinal column caused by increased viscosity 
of cerebrospinal fluids during and after infusion require intravenous hydration of the 
patient before, during, and after infusion to resolve the problem (Patel, Potu, & Sturm, 
2017). Patients with a history of migraines are at an increased risk of aseptic meningitis if 
intervention is not initiated promptly.  
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Research has shown that a clinical guideline should match the needs of a variety 
of patients by anticipating treatment plans through a standing order protocol. Developing 
a standing order protocol for use before the initiation of infusion may facilitate a positive 
patient outcome ( Berger et al., 2013). For instance, the use of standing orders with a 
physician’s approval can assist field nurses in remote locations to address the health care 
needs of the patient when it comes to an infusion and rapid response management 
(CADTH,2011).) In addition, the use of standing orders will provide evidentiary 
documentation of interventions implemented and the patient’s response to the 
intervention along with physician notification. The process of interprofessional 
cooperation involved in developing the standing orders for this project was in alignment 
with the DNP Essentials that calls for the use of interprofessional collaboration in 
managing and advocating for population health (American Association of College of 
Nursing [AACN], 2012).  
Purpose 
The purpose of the DNP project was to improve the quality of care provided to 
patients in the home setting by creating a clinical practice guideline with standing orders 
that incorporated evidence-based research findings. The gap in clinical nursing practice 
that this project addressed was a lack of planned anticipation at the project site of the 
need to manage side effects among patients receiving IVIG at home. The creation of a 
clinical nursing practice guideline would establish a protocol for field nurses and ensure 
delivery of medications before the nurses initiate infusion. In addition, the creation of the 
protocol may improve the safety and quality of nursing care because it will allow field 
7 
 
nurses to provide rapid intervention that efficiently addresses the side effects of patients 
receiving home IVIG. The practice-focused question was as follows: Can an 
interdisciplinary group of healthcare professionals develop clinical practice nursing 
guidelines to assist home health nurses in managing the side effects associated with 
intravenous infusion of immunoglobulin in the home setting? 
The purpose of developing clinical nursing guidelines for home IVIG is to 
improve the quality of care provided to patients. To achieve this aim, I incorporated the 
DNP Essentials I, II, V, and VI (AACN, 2012). These DNP Essentials address the use of 
scientific underpinnings for practice, advocacy for population health through the 
implementation of health policy, the use of organizational and systems leadership to 
improve the quality of care provided to patients, and interprofessional collaboration for 
improving population health (AACN, 2012). I anticipate that the developed program will 
improve care and reduce the cost of the care provided to patients by offering a rapid 
response intervention to manage the side effects experienced by patients during and after 
infusion. I developed the clinical guidelines using an interprofessional collaboration 
approach that uses scientific knowledge.  
The creation of clinical guidelines can help foster a nursing care concept that 
provides a holistic approach based on the best available practice evidence. Establishing 
clinical guidelines may also decrease nurses’ time spent on phone calls and frustration 
from a lack of support while in the field or an isolated region. The development of these 
clinical guidelines may also promote social justice for the community by providing a 
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policy enabling quick access to health care, reduced health care costs, and advocacy for 
the needs of patients (IOM, 2010).  
Nature of the Doctoral Project 
I developed the standing orders for the project in collaboration with other 
professionals. To develop the project, I conducted a literature search using Cochrane 
Library, Google Bar, CINAHL, Medline, and Ovid. Other data sources were the 
guidelines developed by the Canadian Pharmaceutical Associations and the National 
Infusion Society, as well as the Intravenous Immunoglobulin Society. 
To access a wide range of information, I used several key terms in my searches. 
The key terms were as follows: IVIG, IgG, side effects of immune therapy, adverse 
reaction top immune therapy, infusing IVIG, autoimmune treatment, and nursing 
management of immune therapy. I used quantitative and qualitative research studies that 
were peer-reviewed and published between 2010 and 2018. A final synthesis of various 
literature that supports different interventions for managing infusion reactions will then 
be itemized for presentation to an expert panel.  
Significance 
The development of clinical nursing guidelines with standing orders may benefit 
the home health agency by enabling the agency to demonstrate its ability to use research 
data to support practice, specifically the management of patients receiving their infusions 
at home. The patient experience is improved when nurses show their leadership  and  
skills in managing side effects, using evidence based research findings and implementing 
policy changes in a timely and efficient manner (IOM,2011). Also, social change requires 
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that home health companies prepare for the future challenge of being key leaders in the 
cost control of IVIG therapy. Research studies have indicated that U.S. home health 
companies are growing at an increasingly faster rate, more than doubling their original 
expenditure growth by about 2% in  2017 (Reinke,2012). . Financial expenditures on 
home health will grow from 77.9 billion dollars in 2012 to an estimated 144 billion 
dollars in 2021 (Valdmanis et al., 2017). According to Mckinney (2010), there is an 
increasing need to drive health care spending down through interprofessional 
collaboration that promotes the use of home health companies in managing patients, 
which will help reduce emergent care and hospital visits. 
Interprofessional collaboration for prevention and management of side effects is 
important as researchers have noted that hospital visits and emergency room visits in the 
United States are growing faster than the population (Baker, 2017). In their retrospective 
study, Barnum, Bohnenkamp, and Haas (2017) found that nurses have tension regarding 
possible patient response to IVIG; the authors indicated that nursing protocols to guide 
infusion of IVIG can reduce the stress felt by nurses and promoting patient safety. Home 
health companies are viewed as an alternative to hospitals when it comes to the reduction 
of costs associated with specialty pharmacies, especially for IVIG by the government in 
an effort to control the cost of healthcare (Reinke,2012). Home IVIG comes with cost 
savings, and there is a greater need now for health care cost control. Health care costs are 
continuously spiraling out of control, reaching 17% of the national gross domestic 
product (GDP) in 2018 (Globewire, 2018). Specialty drugs account for over 87 billion 
dollars  in the United States today and are estimated to approach 400 billion dollars by 
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2020 (Globe Wire, 2018). IVIG-related costs for specialty pharmacies totaled 8.4 billion 
dollars in 2017 and is expected to increase by 8.5% from 2017 to 2024, reaching 14.9 
billion dollars (Globe Wire, 2018).  
The costs associated with home IVIG are $4,188 compared with $6,916 in the 
outpatient hospital setting, indicating a clear need to switch care to the home setting (Ye, 
Ito, Xiong, & Li-McLeod, 2014). Ye et al. (2014) noted that hospitals have a market 
share of over 80%. The Avalere report compiled on behalf of National Home Infusion 
Association for the Centers for Medicaid & Medicare Services (CMS) indicated a savings 
of almost 80 million dollars if IVIG is infused at home (CMS,2018). However, billing 
must be done by a specialty pharmacy (CMS, 2018) and not nurses.  Reducing this cost 
means that home health agencies must be adequately prepared to take a leadership role 
through policy changes that promote patient safety and improved quality and stability of 
care. 
Part of the hesitancy in the rapid development of home IVIG is a paucity of home 
health companies utilizing research evidence and their slow rapid response in managing 
symptoms. A research study noted that physicians were hesitant of high dose home IVIG 
based on the ability of home nurses to manage patient’s side effects or any problems that 
develop during home infusion rapidly (Reinke, T. 2012).  Another retrospective study by 
neuroimmunology physicians argued that premedication before, during and after the 
infusion was effective in managing side effects (Pahwa, Allan, Howard &Nizar, 2015).   
A trend is, however, developing in support of home health agencies as a better alternative 
when it comes to cost management (Ye et al., 2014). The Center for Medicare Services 
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(CMS, 2013) enacted a policy that now allows for the payment of home IVIG to home 
health agencies. Part of the reason behind the enactment is to determine the cost-
effectiveness of home IVIG and the costs associated with managing side effects. 
 The DNP project will contribute to the practice of nursing in other home health 
agencies. Home health agencies get reimbursement on documented core measures that 
review process, outcome, and utilization measures (CMS, 2018). There will be an 
increase in the reimbursement rate for home health agencies because of a reduced 
utilization score on emergent care utilization by patients (CMS, 2018). The 
implementation of this project can improve both the process and outcome measures, thus 
increasing the quality of care provided by patients and the results of the Consumer 
Assessment of Health Care Providers (CAPS) survey, which is based on patient 
experience (CMS, 2018). Home health reimbursements and star ratings are done using 
questionnaires to ask patients about their experience with the agency. The home health 
agency will also benefit from patient retention, thus improving its bottom line. The ability 
to complete the care process means full reimbursement to the agency without a cut in 
cost. Implementation of the current evidence-based project using a standing order could 
be a great contribution to the skill levels of home health companies because evidence 
shows that the current project generalization to other home health agencies.  
 The DNP project provides an opportunity for a holistic approach toward patient 
care through the anticipation of associated side effects related to the treatment. The DNP 
project provides the home health agency the opportunity to solve the problem that 
prevents physicians from ordering IVIG because the home health agencies can now show 
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their skill in the use of evidence-based practices in developing a clinical standing order 
for a rapid response in patient management to improve the safety of care in a home 
setting.  
The guidelines will support the home health agency and other home health 
agencies in anticipating the care of patients receiving IVIG at home, preventing frequent 
hospitalization and improving the quality of care. Home health agencies can also show 
that they are aware of issues regarding having a rapid response and that they are prepared 
to use evidence-based research to lead the way in affecting policy changes.  
Summary 
The development of a clinical nursing guideline for home IVIG is a quality 
improvement project that would allow nurses to implement a rapid response intervention 
to mitigate patients’ symptoms and side effects without needing emergent care. The role 
of the nurse as an advocate for the patient includes using the nurse’s training and 
professional practice to develop a policy that can bring about a positive change. The call 
for action includes creating a policy when there is a clear gap in knowledge. Developing 
a standing order that delineates instructions for the safe and rapid response to mitigate 
side effects is an important part of filling this knowledge gap.  
The development of clinical nurse guidelines in the management of side effects is 
not only a safety issue but also a quality improvement one that advocates for the patient’s 
safety and that uses the scholarship to promote efficient and cost-effective methods of 
care delivery. The use of practice guidelines improves the knowledge base of nurses 
because new nurses will have a teaching resource during their orientation and learning. It 
13 
 
will also show the growth of the nursing profession and its ability to collaborate among 
disciplines to promote a plan of care for patients instead of being passive bystanders in 
the management of the symptoms associated with home IVIG. Section two will discuss 
the concepts and theories, the relevance to nursing practice, the background and context, 
and the role of the DNP student and the development team. 
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Section 2: Background and Context 
Introduction 
The home infusion of IVIG remains a safety issue for the U.S. health care 
industry due to side effects associated with each infusion and inaccessibility of essential 
medications required for rapid response by nurses. For field nurses, ensuring quick access 
to care, which is a significant part of the patient safety goal (IOM,2010).and managing 
patients during and post-infusion remain problematic. There is a mandatory policy that 
requires EpiPen available in the homes of all patients receiving IVIG(CADTH,2011) 
However, other severe side effects have not received the same uniform health care policy 
for rapid response management (CADTH,2011).  The safest option for patients seeking 
immediate relief is emergent care in the absence of an existing policy guideline targeting 
prevention which is in line with safe nursing practice and ethics to do no harm  in 
accordance with American Nurses Association[ANA,2011].  
The utilization of emergent care is, however, viewed in a negative light by the 
CMS as well as insurance companies due to the additional cost associated with such visits 
(CMS,2018). The local home health agency does not have a system in place for rapid 
response management of side effects but rather relies on hospitals for immediate care or 
until next infusion cycle to allow for orders to be processed by a specialty pharmacy. To 
improve patient outcomes, reduce utilization, and improve process measures, a system of 
quality improvement by the local agency needs to be in place.  
The practice-focused question centered on whether the use of a nursing practice 
guideline based on an interprofessional collaboration could help nurses manage the side 
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effects of patients in the home setting thereby decreasing the use of emergent care and 
providing a better outcome for those patients susceptible to significant side effects. The 
main purpose of the DNP project was to develop a nursing practice guideline based on 
interprofessional collaboration to manage patients’ side effects and thus prevent 
hospitalization while improving outcome and process measures, reducing utilization of 
high-cost resources, and decreasing the cost of care. The guideline will include a system 
of uniform standing orders that are signed by the physicians to allow for the processing 
and delivery of essential medications in the patient’s home before the initiation of 
infusion therapy. The adoption of a clinical nursing practice guideline that focuses on 
anticipated side effects and allows such medications to be made available for nurses in 
the patient’s home may reduce hospitalizations and improve patient safety and experience 
((CADTH, 2011).  The philosophical view of nursing as a profession that uses knowledge 
to guide practice (McEwen &Wills, 2015) lent credence to the project. 
To answer the project question, I drew from the scholarship of explication, 
integration, and application, specifically Betty Neuman’s (1988) theorizing and the RE-
AIM framework (Holtrop, Rabin, & Glasgow, n.d.). Neuman’s theory is in line with the 
propositivist and positivist philosophies of nursing, which support the use of knowledge 
to answer questions when the gap in knowledge exists (McEwen &Wills, 2015). 
Advocating for patients requires that nurses use knowledge of the patient environment, 
disease processes, past medical history, coping mechanisms, and treatment regimen to 
anticipate and plan quality care that restores patients to their optimal level of healthcare 
promptly ((McEwen &Wills, 2015).. The use of Betty Neuman theory in the project 
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works well as it takes into consideration the role of nurses as both an advocate and a 
planner in the management of patients. The RE-AIM framework  evaluation matches the 
performance improvement and policy guideline of the home health agency as it assess the 
effectiveness, sustainability, reach and effectiveness of the program both in the 
organization and the population that they serve.  
Concepts, Models, and Theories 
I have used Newman’s systems theory to support the importance of advocacy for patients 
through a multi-systems-centered approach. The theory views the patient as a whole 
system, with the nursing intervention aimed at providing the best possible care that can 
bring maximum satisfaction and outcomes for the patient (McEwen &Wills, 2015). In all 
professional interactions with nursing professionals, the patient must receive care that 
improves his or her experience and care (American Nurses Association, 2011). Nurses 
must plan care that anticipates the needs of the patients; as the American Nurses 
Association (2011) noted, caring for patients involves planning at each step of the nursing 
process and putting interventions in place to mitigate negative experiences. The planning 
of such care should involve a clear understanding of the variation in patient factors and 
associated side effects of the infusion and putting in place interventions to mitigate any 
potential side effects promptly ((McEwen &Wills, 2015). The nurse must assess the 
patient’s environment and stressors to ensure that the patient receives the best possible 
care (McEwen & Willis, 2014).  
RE-AIM is a framework that is used to evaluate the impact of clinical outcomes 
and their implementation not only in the targeted population but also in the organization 
17 
 
and community (Holtrop et al., n.d.). Use of t RE-AIM framework was therefore essential 
in proving the sustainability of the clinical practice guideline as it provides a foundation 
to measure the impact of the clinical nursing guideline, its effectiveness, the method used 
in adopting and sustaining the guideline, the implementation process, and its 
maintenance. The RE-Aim framework includes five different dimensions to review and 
assess the effectiveness of an outcome and its overall impact on the organization and 
community: reach, effectiveness, adoption, implementation, and maintenance (Jung et al., 
2018).  
I used the RE-AIM framework to assess the sustainability and maintenance of the 
guideline. Owners of the homehealth agency were able to assess the benefit of the 
guideline to their organization, how they can sustain it, and its benefit to the targeted 
population and the community. Use of the RE-AIM framework also provided a 
foundation for the review and transferability of the guideline to other home health 
agencies and the health care community. Jung et al. (2018) used the framework to 
evaluate the sustainability of a community based, practice-focused healthy weight 
initiative. In addition, Baba et al. (n.d.) used it to evaluate the impact of a walking 
program in a disadvantaged community. The quality improvement nurse uses 
documentation of positive patient outcomes to compare with previous outcomes to 
evaluate the successful implementation of the project (Jung et al. (2018).). 
The current project supports the AACN (2012) guidelines on interprofessional 
collaboration, which promote sharing of professional communication and actively 
seeking to work across disciplines and communicate clinical skills among disciplines 
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(AACN, 2012). In this context, a practice guideline provided evidence of nursing as a 
science, which is based on the integration of evidence-based data in the practice of 
interventions provided to patients (Krom, Batten, & Bautista, 2010). 
For the project, I used an interprofessional collaboration framework to develop a 
standing order for the utilization of the delivery of rescue medications to the patient’s 
homes and the implementation of care by the nurses. The use of a standing order allows 
for collaboration among disciplines by using professional communication among experts 
to bring about a better outcome for patients (Dongen et al., 2016). 
Relevance to Nursing Practice 
The present health care system calls for the provision of high-quality care at a 
reduced cost, using the best available evidence-based practice(Mckinney,2010). The 
increasing cost of IVIG and its associated health care costs require policy implementation 
that targets cost-saving while promoting quality improvement that provides patients with 
the best possible nursing care.  Efficiency and improved nursing care, Patient safety, and 
wellbeing depend on the provision of quick access to care (IOM,2011). Patients receive 
improved quality of care when a group of professionals works together to develop a 
shared professional communication and data that improve patient outcomes (Dongen et 
al., 2016). Health care professionals are challenged to provide the best possible outcome 
for patients at a reduced cost using the best available interventions that focuses on 
evidenced based research and practice.  The purpose of providing home IVIG is to 
improve cost-savings and patient comfort (C.M.S,2018). Although immune treatment is 
effective in disease management, the pharmaceutical costs associated with it have 
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increased by up to 20%, accounting for over 87 billion dollars in government spending in 
2012, and this is expected to top over 400 billion dollars by 2020 (Bradford, Balu, & 
Schulman, 2014). IVIG costs are part of these expenditures and have increased by 8% in 
2018 alone, with an annual cost of 2.8 billion dollars in drug costs alone(Globe 
Wire,2018). The above-stated cost in dollars does not include the costs of treating side 
effects, miscoding side effects, undertreating side effects, emergent care, or 
underdiagnosing side effects, not to mention the actual nursing for the administration of 
the product. 
Therefore, it is crucial that nurse leaders develop a quality improvement method 
that prevents additional cost associated with management in the patient’s home by 
preventing the use of emergent care services. Rapid interventions for the management of 
symptoms during and after infusion have been shown to dissipate symptoms and reduce 
the need for emergency room visits (Pahwa et al. (2015). Successful and quick 
intervention requires the implementation of clinical nursing guidelines to manage 
symptoms immediately (CADTH, 2011). The implementation of clinical nursing practice 
guidelines will ensure that essential medications are available for a rapid response in the 
patient’s home. The ability of the nurses to intervene quickly by administering rescue 
drugs allows them to complete IVIG treatment without interruption. Evidence-based 
research has shown that infusing patients in a home setting can save the government 
several hundreds of dollars per infusion episode; this is a significant saving in costs when 
calculating the number of patients receiving infusions at home (Dowell, Moss, & Odedra, 
2018). The introduction of a clinical guideline will assure physicians of the safety of 
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patients and an indication of improved quality of care. Research studies have shown that 
because of the guidelines for the rapid management of blood transfusion reactions, the 
health care industry should also develop guidelines for the management of home 
IVIG(CADTH,2011). The DNP student must use a combination of integrative and 
application scholarship learned to promote the growth of the profession by implementing 
an evidence-based practice where a gap exists through the creation of a standing order-
based nursing guideline. The American Nurses Association (2011) called on nurses to 
practice to the full extent of their profession and be advocates in influencing change for 
patients, and these policies fulfill the need for such change. The DNP essentials require 
that nurses use their scholarship to influence and improve the system organization where 
weakness occurs (AACN, 2012). 
Local Background and Context 
The setting for the DNP project is a natural setting of a home health agency 
located in a community of over 100,000 in the south-western United States. The agency 
specializes in IVIG therapy to adults with varied diseases. The home health agency cares 
for patients in a region of over 200 miles that has both urban and rural settings. The home 
health agency is well suited for the project because the agency is a member of the 
Immunoglobulin Society (IgNS). The patient census is routinely over 100 adults aged 18 
years and older who are receiving intravenous immune therapy for various disorders. As 
part of the DNP clinical experience, interviews were conducted with the administrator, 
quality improvement coordinator, and the director of nursing to determine if the local 
agency is using evidence-based research information in planning and initiating infusion 
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therapy and managing the side effects; the interviews revealed a lack of evidence-based 
research studies in practice. The company still uses doctors’ orders and does not make 
any effort to anticipate needs before sending field nurses to implement care. Nurses are 
required to document and report side effects. The clinical gap is that field nurses are 
instructed to abort infusion should side effects occur that available medications cannot 
control until further orders from physicians.  Emergent care services can be activated for 
patients meeting the criteria until further orders from the physicians.  Although a nursing 
intervention requires physician notifications for additional orders to manage symptoms, 
initiating contact with the physician does not resolve the problem in an expedited manner. 
The reason for this is because physicians must call orders into a local pharmacy for a 
dispensation and because the local pharmacy often does not have rapid response 
medications available. These delays lead to the worsening of symptoms, termination of 
infusions, and the patients needing urgent care. The use of this practice increases health 
care costs that could have been prevented through the establishment of a clear clinical 
nursing guideline for the timely management of potential side effects.  
Role of the DNP Student 
As a Clinical Nurse Specialist that manages infusion of specialty drugs in the 
local home health setting, I have a unique knowledge of the processes and complex 
health care specialization and fragmentation that gave rise to the knowledge gap.  For 
over ten years, I have been in a position to observe the trend and rise in specialty drug 
pharmacy.  The need to control the rising cost of specialty drug gave rise to shared 
benefit that ultimately left the control of drug dispensing and nursing reimbursement to 
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pharmaceuticals. The change that gave pharmaceuticals financial power over nursing 
changed the dynamic of autonomy of nursing in the specialty drug industry as nursing 
became relegated to that of direct patient care. Specialty drug companies, due to their 
lack of nursing experience, often give home health companies limited information and 
adequate time to plan and anticipate needs. As an insider in the process, I have the 
intimate knowledge of the problems facing field nurses in the patient’s home setting. I 
have also noted the frustration faced by nurses as they manage patients with limited 
resources. I have, on numerous occasions, worked in coordination with field nurses to 
prevent escalation of patient conditions and bring about a positive outcome.  My 
numerous experiences in triage calls and interaction with other disciplines and regulatory 
agencies gave me the experience needed to manipulate and effect a policy process 
through communication centered on the benefit to patients as our mutual goal.  My 
position as a clinical nurse specialist in charge of infusion has provided an opportunity 
for interprofessional collaboration between the interdisciplinary team involved with the 
process of care delivery.   
While the gap in knowledge has been an ongoing problem in the home health 
setting, my experience as a DNP student has given me the scholarship needed to use 
philosophical thinking of nursing to seek knowledge that answers the focus question in 
the research study. While I recognize the existence of health care challenges associated 
with the guideline,  both at the micro  level such as the organizations ability to maintain 
the guideline, nursing ability to document exact assessment associated with each 
intervention: and macro levels such as additional cost of documentation, cost to patients 
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and insurance companies, the current movement to use home health agencies to save cost  
have provided an opportunity to make the project a success.   As required by the DNP 
essentials, I will utilize a leadership role in organizing and implementing the project. The 
DNP student is instrumental in promoting change by noting clinical problems and using 
education gained to close the gap in knowledge (Moran, Burson & Conrad, 2017). As 
future leaders, it is the DNP student’s responsibility to continue to foster the growth of 
the nursing profession through the utilization of evidence-based research practice 
(Sherrod & Goda, 2016). Part of that leadership responsibility is developing a clinical 
nursing guideline that not only assists in the management of side effects but also the 
education and orientation of the future generation of nurses. It allows nursing to be 
viewed as a profession, not an occupation because DNP students can use theories to 
translate knowledge into evidence (Terry, 2018). The development of nurse-led 
guidelines will refocus the role of nurses as equal partners in managing patients.  
Role of the Project Team 
The panel of experts was be made up of five registered nurses trained in home 
health IVIG, a specialty pharmacist, and a physician specializing in IVIG. The office 
administrator was consulted to determine the effects of the guidelines on insurance 
reimbursement and the ability of the organization to effect changes implemented. The 
role of the panel was to determine the assessment and management of side effects from 
very mild to severe, nursing actions to be taken at each step to prevent escalation, 
standing medication orders according to protocol, and checklists for monitoring the 
results of interventions based on the Appraisal Guidelines Research and Evaluation 11 
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instrument (AGREE II). The project used clinical practice evidence that focuses on the 
use of the scientific method to support evidence. Based on this, the grading of evidence-
based research utilized levels I to VI evidence. The use of high-quality evidence will 
make the guidelines transferable to other home health agencies.  “ 
 The practice focused question to be addressed was whether an inter-disciplinary 
group of healthcare practitioners can develop clinical practice nursing guidelines to assist 
home health nurses in managing the side effects associated with the intravenous infusion 
of immunoglobulin in a home setting?  
Addressing the clinical question requires a team of experts instructed on the 
AGREE II (2017) guideline and the usefulness of the AGREE II guidelines in the 
development of a quality improvement project to assist the home health organization. I 
educated the panel on the AGREE II consortium guidelines (2017).  The AGREE II 
(2017) guidelines use a set of 23 items with six domains that address quality 
improvement guideline development in an organization. The use of research evidence in 
establishing the guidelines will assist the team in deciding on the best medications for a 
rapid response and the rigors anticipated in the development of the guidelines.  My 
leadership role involved analyzing the research evidence, grading, and presenting the 
evidence to the panel of experts. Part of the development of the guidelines is the 
identification of the stakeholders, who are not only the patients who can obtain a direct 
benefit from the intervention but also the insurance companies and the organization 
through cost reduction and cost-effectiveness. The team is responsible for making the 
decision on how clinical practice nursing guideline based on a uniform standing order 
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developed from the evidence-based research practice will be disseminated and the role of 
champions and leaders in marketing and diffusion of information.  
The team worked together to ensure that the guidelines developed are within the 
regulations of the state for home health companies. The team of experts must review the 
details of the standing orders and add or remove data that are not within the scope of the 
practice of the company based on federal certification rules. After physician endorsement 
of the plan, the team worked together to develop a standing order that will guide the 
home health practice. The plan will start with one physicians’ group of patients and then 
will be marketed to other physicians that order IVIG for patients. 
Once approved by the administration and quality improvement committee, field 
nurses will be required to undergo training in the interventions and associated 
documentation to evaluate the effectiveness of the intervention. Future evaluation of the 
project will be done at the organizational level using a combination of formative and 
process evaluations (Hodges & Videto, 2011) along with the Re-AIM framework to see if 
positive patient experiences are present (Jauregui et al., 2015). 
Summary 
The use of nursing guidelines in the management of side effects is not only a 
safety issue but is also a quality improvement effort that can save on the unnecessary 
costs associated with the utilization of emergent care, improve the quality of care by 
allowing therapeutic management to continue, and allow for quick access to care. The use 
of practice guidelines improves the knowledge base of nurses because new nurses will 
have a formula for interventions and a way to document the symptoms exhibited by 
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patients. It also allows for collaboration among disciplines because nurses will become 
more involved in the plan of care instead of being passive bystanders in the management 
of symptoms. Section three will describe the sources of evidence and the process for 
analysis of data. 
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Section 3: Collection and Analysis of Evidence 
Introduction 
The need to control increases in U.S. health care spending led to federal approval 
of IVIG administration in the home setting (Ye et al., 2014). However, IVIG has 
numerous side effects such as nausea, vomiting, urticaria, headaches, migraines, and 
hypertension that require the establishment of a protocol for the safe management of 
patients in the home setting (Hachulla et al., 2018). Infusing IVIG in a home setting has 
the potential for adverse reactions, thereby jeopardizing patient safety if not managed 
promptly using the best available evidence (ANA,2011).  Home health agencies and 
nurses face potential legal implications if the patient’s safety is at risk because of a delay 
in quick access to care which is part of nursing ethics and code of conduct(ANA,2011).  
To mitigate the risk factors that occur with infusion, the pharmaceutical and medical 
community have suggested medical management using antihistamines, antipyretics, and 
Epi-Pens for all patients undergoing home IVIG (IgNS,2018). 
In a home health setting, a problem arises, however, when field nurses encounter 
symptoms that require additional and immediate interventions other than a repeat of 
Benadryl and Tylenol or a lowering of the rate of infusions. Specific nursing guidelines 
are lacking that can improve the quality of care provided to patients should these(see 
Appendix  (interventions fail to control side effects. The lack of guidelines has led to 
inconsistencies in the ways different home infusion agencies manage patients raising 
doubts about home health agency preparedness for home infusion (Reinke,2012).  Some 
nurses use pumps to regulate the infusion while others free flow the infusion resulting in 
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a lack of consistency and guidelines. Patients are often sent to the emergency room when 
nurses are unable to manage the side effects with antihistamines and Tylenol  for safety 
purposes and nursing professional  ethics demand on malfeasance (ANA,2011). Health 
care leaders should be aware of the cost associated with frequent emergency care and the 
increasing attention on cost control and improved quality of care when planning care. The 
utilization of emergency care should be a last resort as it negates the reason for home 
infusion. The universal requirement for EPI-PEN in homes of all patients receiving IVIG 
in the home setting is for the management of anaphylactic reaction and does not assist in 
the management of side effects (CADTH,2011). 
Due to the lack of the availability of rapid response drugs, patients and field 
nurses often resort to emergent care for the management of side effects; this practice 
further increases health care costs. It is therefore important to establish a clear clinical 
nursing guideline in local health care settings using a standing order system that allows 
for the delivery of essential rapid response drugs. The creation of clinical nursing 
guidelines based on interprofessional collaboration and high-level research evidence will 
ensure that specialty pharmacies can deliver the rapid response medications needed in the 
patient’s home in anticipation of side effects (Krom et al., 2010). 
Practice-Focused Question 
The practice-focused question for this project was, Can an interdisciplinary group 
of healthcare professionals develop clinical practice nursing guidelines to assist home 
health nurses in managing the side effects associated with the intravenous infusion of 
immunoglobulin in a home setting? 
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Purpose 
The purpose of the project was to determine if the use of clinical nursing 
guidelines will close the gap of knowledge that exists in managing the side effects of 
home IVIG and provide organized clinical practice guidelines for the management of side 
effects experienced by patients receiving home IVIG. If essential rescue medications are 
delivered to the patient’s home for use by nurses, the cost of emergent care for symptom 
management may be reduced significantly. Anticipating the needs of patients improves 
quality and enables patients to receive the best care possible, which is a part of the 
nursing profession paradigm (McEwen & Ellis, 2014). 
Sources of Evidence 
I completed an evidence-based literature review using the following databases: 
Medline, CINAHL, ProQuest, Cochrane Database of Systematic Reviews, and Google 
Bar which I accessed via Walden University Library. I limited my searches to literature 
published from 2010 to 2018 and used key words to ensure all-inclusive criteria such as 
the common symptoms associated with the infusion of IVIG. The focus of the search was 
on collecting evidence that generalizes the management of side effects experienced by 
patients during IVIG. The side effects targeted during the search were the most common, 
as noted by research, and included headaches, nausea, vomiting, migraine, hypertension, 
fluid overload, renal insufficiency, and blood clots. In searching for evidence, I also 
reviewed literature that supports a rapid response and its significance to both patient 
safety and the promotion of the nursing profession. In addition, I reviewed literature to 
determine if there are any existing guidelines available. 
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In their meta-analysis of evidence-based articles, Markvardsen et al. (2015) noted 
that transient side effects occur in more than 50% of the population of patients receiving 
home IVIG. It is also a recommended requirement that the health care industry encourage 
patients receiving home IVIG to maintain an open phone line and an anaphylactic kit 
consisting of epinephrine, Benadryl, and Tylenol in case of a life-threatening 
anaphylactic reaction occurring during the infusion (CADTH, 2011). The reason is to 
promote quick access to care and promote high quality care. 
In another meta-analysis of evidence-based research, the authors noted that over 
60% of patients receiving IVIG manifest reactions such as nausea, headaches, flu-like 
symptoms, blood pressure, congestive heart failure, rash, spasms, and restless legs, 
despite the pretreatments given (Hachulla et al., 2018). Patients with a history of 
migraines have been shown to have a greater occurrence of aseptic meningitis with the 
infusion and should be monitored and treated promptly to avoid the escalation of 
symptoms (Markvardsen et al., 2015). Patients who have been known to suffer from 
blood viscosity are treated with hydration or blood thinners during the infusion 
(Bonila,2014).Hypertension and stroke patients have a risk of increased symptoms if 
adequate intervention is not performed and implemented rapidly (Markvardsen et al., 
2015).  
Hachulla et al. (2018) noted that side effects could be managed by decreasing the 
rate of infusion and medicating patients with essential drugs if these drugs are available 
in the patient’s home. Patients can also exhibit elevated blood pressure, fluid overload, 
and a thrombolytic process (Berger et al., 2013). The present recommendation is for field 
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nurses to assess, document, and notify physicians of symptoms for management (Vokey, 
2013). This recommendation, however, does not allow for the rapid intervention of 
symptoms in home settings or give nurses the ability to practice to the full extent of their 
professional education.  
In its meta-analysis, CADTH (2011) noted that certain side effects are common 
among patients receiving intravenous IVIG and that the role of nurses should not only be 
based on physician notification but rather on policies that can create a rapid response in 
the home setting through interprofessional collaboration. Nurses must also use leadership 
to create guidelines through interprofessional collaboration that aims to reduce health 
care costs and improve the quality of care provided to patients (Price-Dowd, 2018). 
Although a nursing intervention requires physician notifications for additional orders to 
manage symptoms, initiating contact with the physician does not resolve the problem in 
an expedited manner because the orders must go to the local pharmacy, which generally 
does not have the rapid response medications in stock  that is often carried by specialty 
pharmacy(Bradford &Schulman, (2014). These delays in the activation of care often lead 
to a worsening of symptoms, possible abortion of infusion, negative patient and family 
experiences, and sometimes the need to use emergent care indicating lack of quick  
access, increase in health care cost and delay in care (Mckinney, 2010).    
The creation of a clinical nursing protocol may assist in the resolution of these 
problems by increasing the ability of a rapid response (see Barnum et al., 2017). 
Specifically, a clinical nursing practice guideline implemented based on interprofessional 
collaboration with a specialty pharmacy and the physicians while keeping the patient at 
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the center of care may ensure the availability of the essential quick response medications 
needed by home health field nurses. The availability of essential medications assists field 
nurses in performing interventions; it also improve the quality of care, allowing for the 
completion of infusion, reduction in emergent care visits, and improved patient 
experiences in compliance with the need of Affordable Care Act to reduce spending and 
improve quality of care at a reduced cost (Oberlander,2016).  These guidelines can also 
reduce the stress encountered by nurses who are in a remote location and trying to 
manage symptoms because of a lack of the availability of rescue drugs. The project team 
developed the guidelines based on common symptom anticipation and quick action 
medications, here consisting of intravenous and oral medications. The availability of 
these drugs will reduce the anxiety associated with the lack of available medications in 
the home for the management of symptoms (Olson et.al, 2016). Cost savings may also 
occur because nurses can focus more on the management of patients and documentation 
of patient experiences.  
Having nurses assess and notify physicians as the only intervention is a patient 
safety issue that goes against the recommendation of the IOM’s report that called for 
nurses to use leadership skills in affecting changes in policy (IOM, 2010). This report 
also recommended that nurses should be allowed to practice to the full extent of their 
profession and education (IOM, 2010). Clinical nursing guidelines developed in the form 
of standing orders by the home health agency would work to improve the quality of care 
by reducing response time and improving the provision of timely interventions needed to 
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improve the quality of care provided to patients, as well as promoting the skill sets of the 
nurses involved. 
Nursing assessments and interventions are crucial for patient safety, and it is 
therefore important that nurses anticipate interventions by establishing guidelines that 
make it possible for a specialty pharmacy to supply rapid intravenous response drugs in a 
patient’s homes before initiating an infusion. The availability of these drugs will assist 
field nurses in the implementation of interventions and documentation for further 
evaluation and cost-effectiveness. 
There is a clear correlation between the various research articles indicating that 
health care professionals should anticipate the needs of their patients and should, 
therefore, implement the use of anticipated interventions for the rapid management of 
side effects. A meta-analysis article based on a 20-year review of different brands of 
IVIG determined that there is a clear similarity in side effects such as headaches, nausea 
and flu-like symptoms (Saeedian & Randhawa, 2014). The study supported the premise 
that the knowledge of the most common side effects associated with the different brands 
of IVIG should form the basis for the planning and anticipation of the needs of patients in 
a home setting.  
Depending on physicians for the complete management of IVIG related side 
effects has created the lack of back-up medications needed for rapid intervention at the 
patient’s home, which is a safety concern. Some physicians have a developed standing 
order for nurses to follow, which has proven effective for the local home health agency in 
managing patients’ symptoms (Pahwa, Allan, Howard & Nizar,  2015). However, the 
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development of standing orders by some physicians does not exonerate nurses from 
rendering their professional leadership responsibilities. The use of a uniform clinical 
nursing practice guideline that sets as its goal, patients’ safety, and risk reduction for the 
nurses provide a positive outcome for the company.  As professionals, nurses must use 
leadership to influence change that can bring about a positive social effect on the society 
that they represent. 
Support for the Clinical Question 
The evidence noted in the review support the anticipation of interventions for the 
management of side effects experienced during an infusion. It is not enough for the nurse 
to document the side effects and allow the patient to suffer in discomfort. Nurses must 
also take an active part in initiating and making policy changes that seek to advocate for 
the patients and promote their safety. The use of a holistic approach in planning nursing 
care is in line with Betty Neuman’s theory, which states that the patient should be treated 
as a whole system and provided with the best and most optimal care (McEwen & Wills, 
2014).  In the evaluation of the project’s outcome and its suitability to the local 
organization, the formative and the RE-Aim framework will be used to determine the 
impact and effectiveness of the project in addressing the needs of the patients and the 
outcomes of the quality improvement (Miake-Lye, Amulis, Saliba, Shekelle, Volkman, & 
Ganz, 2011).   
 A review of the literature noted that analyzing each patient’s history and planning 
for care can mitigate side effects (Markvardsen et al., 2015). Nurses administering IVIG 
to patients with a history of hypertension, arterial fibrillation, renal failure, and migraines 
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should anticipate an escalation of blood pressure, possible congestive heart failure, blood 
viscosity fluid overload, and migraines. Therefore, an intervention should be planned and 
ready to be implemented should the patient need it (Berger et al., 2013).  Planning of care 
for patients with a history of migraines should include anticipation of aseptic meningitis 
which is characterized by severe headaches and nausea with or without vomiting during 
and after infusion and therefore should have a management plan for such patients before 
initiating infusion (Patel et al., 2017).  
The CADTH (2011) recommendation guideline on home IVIG supports the need 
for a rapid response by anticipating common side effects associated with IVIG infusion, 
noting patients susceptible for uncommon side effects based on co-morbidity and then 
implementing a plan of care that makes it easy for the safe delivery of infusion in the 
patient’s home.  Making such anticipation and management based on common side 
effects and history includes the slow rate of infusion for patients with renal failure, blood 
thinners for patients with a history of thrombosis and providing analgesics for Headaches 
(Thornby et al.,  2015).  However, while it is important to document and research side 
effects and associated management, research articles noted that guidelines be created for 
future use, much like what has been done it with the blood transfusion guidelines for a 
uniform use across the health care industry (CADTH, 2011).  
A great part of the new health care paradigm is the use of evidence-based research 
to support clinical practice and, when there is a gap, to ask scholarly questions that 
provide the needed information (Michael & Clochesy, 2016). In his article on the 
development of a standardized form for the management of side effects associated with 
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chemotherapy, Butcher (2011) argued that the anticipation of such standards could assist 
in reducing patients’ side effects, improving their experiences, and allowing them to 
receive the treatment needed to manage their disease process. Clarke (2010) also noted 
that the complex health care of patients, disease process, need for cost control and need to 
use the available resources in an effective manner calls for the use of interprofessional 
collaboration in the management and development of quality improvement programs for 
the management of patients. The use of clinical nursing guidelines supports the utilization 
of interprofessional collaboration in managing the side effects associated with IVIG. It 
means that all members of the healthcare team must work in professional collaboration to 
promote the best outcome for patients (Clarke, 2010).  McKinney (2010), in his article on 
stroke team noted that teamwork produces a better patient outcome and therefore 
supports the need for teams to work together to control the cost of health care by reducing 
redundancy, acting in a preventive way while providing high-quality care. It noted that 
high costs do not necessarily correlate with high-quality care if teams do not work 
together to remove fragmentation (McKinney, 2010). 
Analysis and Synthesis 
The purpose of analysis and synthesis of evidence for this project was to critically 
analyze, appraise and use the evidence to address the problem of creating a uniform 
guideline clinical nursing guideline for effective and rapid management of side effects of 
intravenous immunoglobulin in the home health setting due to its remoteness. The 
analysis and synthesis of the level of research evidence obtained in the project 
evidentiary process will utilize the profile and steps stipulated by   Melnyk and Fineout-
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Overholt (2011) and Mantzoukas (2009).  During the initial step of the project analysis, 
evidence obtained was sorted out utilizing both tables and graphs to arrange them in a 
level of the hierarchy that places quantitative data above qualitative analysis.  Level 1 
evidence uses a systemic review of the data. Level 11 is a randomized controlled trial. 
Level 111 evidence contains data from quasi-experiments, and level V1 is descriptive, 
predictive correlational and cohort studies. Mixed method research, descriptive and 
qualitative study, and expert opinions were placed in levels V, VI, and VII, respectively.  
The Mantzoukas classification tables are utilized in the methodology of research 
evidence, specifying analysis of the evidence into quantitative and qualitative tables with 
specified naming nomenclature for quantitative research and qualitative research (Gray, 
Grove &Sutherland,2014). The determination of the type of study is through an analysis 
of the abstract.   A listing was compiled that addressed the management of the most 
frequently occurring common side effects noted during and post infusions of 
immunoglobulin therapy, the associated patient interventions, and drugs recommended 
for management.  The analysis and synthesis of data was provided to the Project Team  
comprising of four  registered nurses with clinical experiences in IG infusion, a 
pharmacist representing the specialty drug pharmacy, the administrator of the company 
and a physician for the development of a table of standing orders using a grading 
criterion noted in the research from mild to severe with an associated patient symptom 
that is deemed mild to severe, a stepwise nursing intervention and documentation for 
each stage and outcome documentation.  This is supported by the rapid response 
intervention recommendation (CADTH, 2011). The guidelines contain a stage for the 
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abortion of therapy, initiation of Epi-pen, and emergent care if patient safety is at risk.  
Part of my responsibility as a leader was to provide the expert panel with a list of drugs 
that are federally prohibited in a home setting and the need for narcotic counts if used in 
the home setting. A statistical calculation was used for the creation of the guideline as it 
related to the most common side effects and drug responsive to treating it.  The project 
team then appraised the guideline using the AGREE II tool. 
Ethical Protections 
The study did not involve the use of human experiments. The participants for the 
study are members of the organization that were assured anonymity in the study. Before 
obtaining the Walden IRB approval, participants  provided the signed consent for the 
project. The maintenance of trade and company secrets was very important to the 
company, and for that reason, the names of participants were masked. Company data 
were not revealed in the study. 
Summary 
The DNP student must use knowledge his or she gained to fill a practice gap 
when that gap is noted (Sherrod & Goda, 2016). There is a clear gap in knowledge in the 
management of patients with side effects of home IVIG. As a leader in the profession, it 
is an essential duty of the DNP student to advocate for their patients through a policy that 
develops quality improvement (AACN,2012). Creating a nurse-led standing order in 
collaboration with physicians and specialty pharmacists can enable the delivery of the 
essential drugs needed to manage patients in their homes. Nurse leaders, as part of the 
interprofessional team in the health care industry, should use their education and training 
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in implementing these policy changes of rapid response intervention through the 
utilization of care that anticipates side effects (Toto et al., 2009). The clinical nursing 
guideline for the project was developed based on the methodology that utilized 
systematic review and synthesis of evidence-based research articles. The organization 
used for the scholarship needed to develop the knowledge was based on PICO to ensure 
inclusion of the philosophical thinking and search for knowledge is the foundation for the 
research. The next section is devoted to the findings and recommendations based on the 
synthesis and analysis of secondary data. The findings were utilized in the development 
of standing order. The evaluation of the guideline is based on criteria that improve patient 
outcome and experience. 
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Section 4: Findings and Recommendations 
Introduction 
The clinical practice issue was that the home health agency had no organized 
system in place utilizing a rapid response to manage the side effects associated with home 
infusion of IVIG. Current policy at the home health agency suggests that practitioners 
abort infusion and activate emergent care rather than utilizing an evidence-based clinical 
nursing guideline to introduce standing orders for a rapid response to manage the patient. 
This policy delays the implementation of interventions that mitigate and manage 
postinfusion side effects according to the agency Administrator and clinical nurse 
Manager. There was a gap in clinical care regarding the use of evidence-based clinical 
guidelines with standing orders by local agencies to address the anticipated side effects of 
IVIG. Detailed interventions to guide field nurses in a rapid response of side effects 
during and after infusion in a patient’s home were also lacking. I addressed this gap by 
creating a standing order that rated side effects on a scale from mild to severe (see 
Appendix A). The practice-focused question was, Can an interdisciplinary group of 
healthcare professionals develop clinical practice nursing guidelines to assist home health 
nurses in managing the side effects associated with the intravenous infusion of 
immunoglobulin in a home setting? 
In developing this project, I sought to provide a solution for the management of 
side effects of IVIG in the home setting by creating an evidence-based research clinical 
practice guideline for the home health agency. The lack of a clinical nursing guideline is 
not only a gap in the body of knowledge but also a patient safety issue as quick access to 
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care is a patient safety issue (IOM,2010).  In addition, quick access to care is an 
important part of process and outcome measures (CMS,2018). Establishing a clinical 
practice guideline that incorporates interprofessional collaboration in planning and 
implementation processes is likely to improve patient outcome significantly (AGREE II, 
2017). The ultimate purpose of the project will be to determine whether patient outcomes 
can be improved through the creation of a uniform, interprofessional clinical practice 
guideline for the rapid management of side effects experienced by patients in the home. 
However, this is beyond the scope of this study. I focused on the use of evidence based 
research findings to put into practice, interventions that may improve patient outcome 
during and post infusions of IVIG.   
Findings and Implications 
Sources of Evidence 
I collected evidence for the project from peer-reviewed articles (see Appendix B). 
Evidence was collected from several databases, such as Medline, CINAHL, ProQuest, 
and the Cochrane Database.  Articles were excluded if they were published before 2008 
and if the patients studied were less than 16 years old. I included research published after 
2009 in which patients of 16 years old and older were studied. 
Search criteria included common symptoms and side effects associated with IVIG 
infusion to ensure that data targeted a variety of patients in the home setting. A meta-
analysis and synthesis of articles (Markvardsen et al., 2015) was used to support the data 
on common side effects. Both OVID and the Mankousas grading system( formed the 
bases for the evidence selection method used. A simple frequency distribution was 
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utilized to categorize side effects for the appraisal. Research data used to support the 
project were divided based on the grading scale to ensure that the project used the best 
evidence. A consistent theme in all articles indicated the use of mild to moderate 
analgesics for the management of headaches and migraines, anti-convulsant such as 
Depakote, anti-spasmodic for the management of spasms and severe migraines, and an 
anti-emetic for the management of mild to severe nausea and vomiting (Markvardsen et 
al., 2015). Also, analysis of articles highlighted that slowing the rate of infusion for 
patients with a history of migraines and renal insufficiency is also effective in managing 
side effects associated with IVIG (Bonila,2014). A meta-analysis by Oaklander et al. 
(2017) also supported the findings.  
A recommendation made in a study by Bonila (2014) noted that patients with 
potential for hyperviscosity due to their disease process should have a slow infusion rate 
and hydration with normal saline if possible. Such patients require treatment with 
antiplatelets for days before infusion if approved by their hematologist (Bonila,2014). 
Research findings indicated that steroid administration was effective in managing 
migraine and pressure in the spinal fluid caused by elevated protein levels and the 
consequent cerebral edema associated with such pressure. A common theme noted in the 
articles reviewed was that decreasing side effects both during and post IVIG infusion 
improved patient safety and outcome. It was also important to ensure that nurses had 
within their arsenal essential medications needed to manage side effects.  
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Analytical Strategies 
As the project coordinator, it was my duty to collect and organize the articles 
selected for this research. To ensure that a representative sample of side effects, , I 
focused selection criteria on the most common symptoms. Outliers were analyzed, based 
on the frequency of occurrence and nature of evidence, to ensure equal distribution. 
Symptoms relevant to home management were selected using a frequency distribution. 
The mean and median were used to address rare outlying symptoms that may be observed 
during infusion in some patients. I also provided information on medications federally 
permitted for home use such as [Toradol, Dexamethasone, Valproate, Valium and 
Banadry (CMS,2018).  I explained the rules home health agencies follow regarding 
CAPHS scoring, emergent care utilization, and the effectiveness of the standing order in 
allowing the agency to increase its reimbursement. In addition, I used the opportunity to 
explain to each of the stakeholders the positive social change associated with the 
guideline in terms of both legal and financial benefits. 
As the team leader, I explained the AGREE II (2017) instrument that formed the 
basis for the appraisal of the guideline and the grading system used in each domain to the 
team members. Part of my role as team leader was to meet with the panel of experts made 
up of a clinical pharmacist, administrator, clinical nurse director, medical director, field 
nurse, and quality control nurse on a biweekly basis to answer questions and to provide 
clarification of the data and how the evidence obtained can be implemented by local 
home health care providers. I educated the team on the level of evidence used based on 
OVID and the Mankousas scale and informed them of medications that can be used in the 
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home setting. I also discussed what other healthcare providers were doing to implement a 
system of standing orders for individual patients and methods of cost management and 
control such as prescribing medications that control side effects for patients to have for 
future infusion.   
The meetings presented an opportunity to explain the grading system used in 
evidence-based research and discuss concerns regarding the workability of evidence in 
home health care to avoid vendor conflict, which can impact the referral of patients as 
part of program analysis(Hodges & Videto, 2011). We also used the meetings to address 
the workability of the project within the home health organization and how standing 
orders could be initiated and become part of the company record based on approval by 
the governing body. Approval is required by the regulatory authorities of home health 
agencies (CMS,2018).).  
Information for the expert panel was assembled based on evidence from research 
articles subjected to analysis and synthesis, utilizing a grading system to ensure data 
quality (Gray et al., 2014). After reviewing and debating the evidence, the expert panel 
indicated that the data selected qualified for inclusion in a clinical nursing practice 
guideline. In addition to evidence-based research findings, the clinical nursing practice 
guideline was based on the CADTH recommendations with associated symptoms rating 
(CADTH, 2011).  
I created  standing order  that rated side effects on a scale from mild to severe 
using the data collected (see Appendix A). Each symptom rating was given an associated 
medical and nursing management action that focused mainly on a rapid response 
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intervention. The medical management of side effects was based on medications that can 
be utilized in a home environment and that are federally permitted for home 
administration by the state Department of Health and Human Services and other 
regulatory agencies.  I presented the clinical guidelines and the standing orders   to the 
project team for their final approval and appraisal after dosage review by the pharmacist.  
I presented the panel of experts the updated version of the AGREE II Consortium 
Instrument (2017), a tool that is used to appraise clinical guidelines. It has six domains, 
and each domain contains targeted information for the appraisal (AGREE II,2017). The 
main purpose is to ensure that evidence used in developing clinical guidelines is based on 
scientifically sound data (AGREE II, ,2017). My motivation to use this instrument in this 
study was to ensure a clear method for the assessment and appraisal of sources of 
evidence used to develop the guideline. Also, the AGREE II instrument provided a 
methodological strategy for the development and reporting of the clinical nursing 
guideline. To appraise the articles used as evidence to support the creation of standing 
orders, the five experts were provided with the AGREE II Clinical guidelines, which 
were made up of the six domains listed in the AGREE II Consortium instrument (2017) 
as follows:  
• Domain 1: Scope and Purpose of the Clinical Guideline Statement,  
• Domain 2: Stakeholder Involvement,  
• Domain 3: Rigor of Development,  
• Domain 4: Clarity of Presentation, 
• Domain 5: Applicability of the Clinical Practice Guideline, and 
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• Domain 6: Editorial Independence. 
Each of the domains contained 23 questions used to evaluate the integrity of the 
evidence. Overall, two methods of scoring using a 7-point grading system from strongly 
disagree to agree strongly were utilized in appraising the data. The first method was 
based on an appraisal by individual experts, and the second method was based on the 
consensus between them. The result of both scores was averaged and formed the basic 
unit for the development of the clinical nursing practice guideline. I accepted the experts’ 
scoring. Tables 1 includes the experts’ individual scores; Table 2 includes the consensus 
scores. The tables indicate that the evidence passed the requirements for use in 
developing a clinical guideline.  
Table 1 
Individual Scores Using the AGREE II Consortium Instruments 
Domain Score (%) 
Aggregate 
score 
 1 2 3 4 5 6 7  
1: Scope and Purpose 
9
5 
9
3 
9
6 
9
5 
9
6 
9
7 
9
6 96 
2: Stakeholder 
Involvement 
9
4 
9
4 
9
6 
9
5 
9
5 
9
6 
9
5 97 
3: Rigor of Development 
9
5 
9
7 
9
6 
9
4 
9
6 
9
3 
9
4 95 
4: Clarity of Presentation 
9
6 
9
7 
9
8 
9
6 
9
7 
9
6 
9
6 95 
5: Applicability 
9
7 
9
2 
9
5 
9
5 
9
5 
9
4 
9
4 96 
6: Editorial Independence 
9
4 
9
5 
9
4 
9
7 
9
8 
9
6 
9
7 93 
 
Note. Method 1 was based on individual appraisal scores using the AGREE II guideline 
on evidence submitted. The formula for the score was based on the updated 2017 
AGREE II consortium and was the score from each domain minus the minimum possible 
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score divided by the maximum possible score in each domain minus the minimum 
possible score. 
 
Table 2 
Consensus Score Using the 2017 AGREE II Consortium Instruments 
 Domain 1 Domain 2 Domain 3 Domain 4 Domain 5 Domain 6 
Consensus 
score 
97 95 97 96 94 95 
 
Note. The calculation method was as follows: Obtained score − minimum possible 
score)/(maximum possible score − minimum possible score). A 7-point scale was used, in 
which 1 = Strongly Disagree and 7 = Strongly Agree. 
 
After the ratification of the standing order and the reconciliation of issues of 
compatibility with agency regulation, I presented it to the administrator for final approval 
by the governing body. This is required by the regulatory bodies governing home health 
care agencies before a standing order can be included in agency policy and procedure 
(CMS,2018).. 
Implications for Social Change 
The IOM (2010) report called for the use of inter-professional collaboration to 
develop new knowledge where knowledge gaps exist. Patients benefit when experts 
exchange clinical skills. The implications for social change when this occurs include the 
reduced use of emergent care and a decrease in the financial cost of health care through 
better access to higher quality health care.  
The knowledge developed in the project can easily be used not only by the home 
health agency but also by other home health care providers. The goal of using home 
health as an alternative to hospitals to reduce the cost of health care can be achieved with 
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care that effectively manages side effects is implemented by field nurses in home settings 
without the need for hospitalization.  
Evaluation Plan 
The evaluation plan for the new clinical nursing practice uses  RE-AIM in 
conjunction with formative and process framework. Both processes evaluate the fit and 
sustainability of the project within the organization. The goal is to ensure the project 
reaches the target population, is effective in managing side effects of IVIG promptly, the 
sustainability of the evidence-based practice within the organization maintenance and 
adoption of the project as part of the company policy and procedure manual.  Part of the 
implementation of the guideline and adoption of the project is done during the internal 
phase of the dissemination process as part of the home health agency requirement by the 
federal regulating body. The rules and regulations for home health agencies require that 
all policies be adopted and made part of the patient plan of care. Implementing a patient 
plan of care that uses the project premise ensures that the project reaches the target 
audience and implemented according to the plan of care.   Sustainability and maintenance 
of the evidence-based project are achieved by having the project adopted by the 
governing body and made part of the policy and procedure manual. The overall project 
outcome and effectiveness measurement is through the number of aborted infusions and 
patients seeking emergent care for the sole management of side effects post infusions.  
There is a system in place for tracking outcome measures through the Center for 
Medicare and Medicaid outcome assessment data set ( OASIS). 
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The system of tracking utilization of emergent care and incomplete infusion 
matches the RE-AIM framework and will be used to evaluate the maintenance and 
effectiveness of the standing orders created through comparison with the previous period. 
The quality improvement nurse will be educated as part of the steps to be done during the 
dissemination stage and has a system of tracking in place as required by the home health 
agencies rules and regulations established by CMS. All home health agencies are 
required to perform a biannual quality improvement that focuses on emergent care 
utilization, the reason for the use of emergent care, performance, and outcome measures 
for patients in their care.   
The quality improvement nurse is responsible for evaluating the effectiveness of 
the standing order in reducing side effects, any emergent care visits as a result of side 
effects of IVIG, the cost of adopting the standing orders during the bi-annual quality 
improvement. The final result of the outcome of this project is not feasible at this time for 
compilation by the project leader.   The reason for the lack of compilation is because the 
home health agency compilation of clinical data for quality control uses federal 
regulations. The fiscal period for the collation of actual data on patients based on OASIS  
information that will reveal the outcome for the fiscal year of 2019 reporting is 
December, which is outside the timeline for my program completion. The Agency quality 
control nurse is in charge of data collection and compilation. Based on this fact, the 
quality control Nurse has been provided information for data comparison between this 
fiscal year data and next fiscal year reporting, which is automatically generated by the 
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software. Results of patient experience collected through Press Ganey will be available at 
that time. 
Implications for Patients, Home Health Agencies, and Communities 
The CMS (2017) has suggested that home health agencies reduce fragmentation 
caused by specialization of services in the community and improve the quality of care 
patients receive using care coordination and implementation of inter-professional 
collaboration in the patient plan of care. The goal of using interprofessional collaboration 
in the management of patients is to reduce the redundancy of services, provide quick 
access to care, reduce medication errors, improve the quality of care, and save costs 
through the provision of efficient health care services. The CMS (2018) goal of reducing 
redundancy, financial waste, and the high cost of health care can be achieved through the 
DNP project. The philosophical view of nursing was used to develop a PICO-based 
question that sought to provide an answer to the existing knowledge gap.  
A lack of clinical nursing practice guidelines for rapid response interventions to 
address the side effects of IVIG infusion has led to the frequent utilization of emergent 
care and or the termination of infusion (CADTH, 2011). Delays in interventions to 
address side effects resulting from infusion may result in negative patient experience as 
measured by home health agency Consumer Assessment of Healthcare Providers and 
Systems (CAPHS, 2018) survey scores. A low score on the CAPHS survey results in a 
decreased rate of reimbursement and a low score for the agency in home health 
comparisons conducted by regulatory agencies. The Center for Medicare (CMS) 
currently reimburses home health agencies using a grading system to calculate the rate of 
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reimbursement (CMS, 2018). The grading system uses outcome and process measures, 
emergent care utilization, and hospital stay on a sixty-day recertification cycle (CMS, 
2018). For home health agencies to remain competitive and receive high reimbursements, 
they must maximize their market value.  Improving their market value means emergent 
care less frequently and increasing their scores for patient outcomes and processes.  
At the individual level, patients will benefit from the effective use of the guideline 
as a tool for rapid response that anticipates side effects and their management. As a result 
of the guideline, nurses will be better equipped to intervene on behalf of patients, 
promoting advocacy and positive social change. At the organizational level, the clinical 
practice guideline provides a clear indication that the local agency can meet the challenge 
of engaging in evidence-based practice. The guideline will help the agency become well 
informed and engaged in the positive social change that utilizes evidence-based practice 
to provide care that is efficient and rapid. The creation of the guideline will benefit the 
agency, as the rate of patient hospitalization will decrease, and CAPHS scores will 
increase with the use of the evidence-based practice. Also, the community will benefit 
from the guidelines, as health care practices are supported by evidence. Better access to 
higher quality health care will decrease health care spending. There will also be a 
decrease in the fragmentation of care, as the agency will be able to provide bundled care 
to patients as a result of care planning that includes the anticipation and management of 
side effects. 
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Contributions of the Doctoral Team 
A team of experts from several disciplines, comprising a specialty pharmacist, 
four registered nurses, an administrator, and a medical director was chosen to ensure 
compliance with the Medicare Challenge (CMS, 2017) and the (IOM,2010) initiative on 
the use of new knowledge. The team appraised the research materials as instructed. The 
inter-professional team of experts used the AGREE II guidelines to reach a clinical 
decision based on scientific data that produced new knowledge in the provision of health 
care and the coordination of care amongst disciplines. After reviewing and appraising the 
data for its use in the development of the clinical nursing practice guideline, the team 
presented their findings using the six domains outlined in the AGREE II Consortium 
instrument. Finally, the experts reached a consensus on their rating of the evidence (Table 
2). The scores indicated that all experts gave the evidence a passing score, and the final 
score indicated that the evidence met the required criteria.  
Role of the Doctoral Team in the Final Recommendation 
 Based on the appraisal, a standing order was developed and submitted for further 
review by the expert panel. In total, two-panel members indicated that the standing order 
should provide for over-the-counter medications to be given at home before the infusion, 
as the data indicated that some over-the-counter medications, such as anti-inflammatories 
and analgesics, can manage side effects. Some members suggested that a specialty 
pharmacy should be called during rate adjustments, as the rate of infusion can increase 
reimbursement rate. The recommendations made by the panel were noted and taken into 
consideration in preparing the final standing order for the clinical practice guideline. 
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Plans to Extend the Project Beyond the Doctoral Team 
In the future, it is hoped that the project will be presented at the annual meeting of 
the Immunoglobulin National Society (IgNS) to use this forum to start a discussion on the 
use of a uniform standard of care for patients receiving IVIG. The presentation of the 
findings will provide an avenue that allows home health agencies to improve their cost 
management and control over the health care services. It will also provide a forum to 
present the benefits to home health agencies of creating a uniform protocol for the 
provision of high-quality care to patients in the future. 
Strengths and Limitations of the Project 
Strengths 
The strength of this study was that its recommendations, which were based on 
research evidence, can be translated into practice. The use of a standing order that 
addresses the management of side effects experienced by patients in the home setting 
reduces fragmentation created through the specialization of care. Patients enjoy the 
benefits of receiving acute care in their home, like the type of care they would receive in 
a hospital setting. Home health agencies can show their readiness to tackle the demands 
associated with engaging in evidence-based care in the home setting. The study has also 
contributed to the development of nursing as a profession, as a theoretical basis was used 
to support the project.  
Limitations 
The study limitations in implementing this guideline are potential insurance 
companies’ refusal to pay for medications based on an anticipation of needs. A refusal to 
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pay for medications means that pharmacies are unable to deliver medications needed for 
side effect management in the home setting. Patients limited in resources may be unable 
to finance rapid response medications. Also, physicians who resist change may be 
reluctant to sign off on the standing order. Not having a physician signature would render 
the standing order ineffective, as all orders are required by law to be signed by ordering 
physicians. 
Future projects should consider the cost associated with the management of side 
effects in emergent care post IVIG infusion, as there is a knowledge gap on this topic. To 
fill this gap, emergency rooms must use a coding system that allows for collation of costs 
associated with treating patients for side effects associated with the infusion. Also, future 
projects could address the benefits of ensuring that only nurses credentialed in IVIG 
infusion conduct them in the home setting. However, nursing scarcity and the costs 
associated with paying expert nurses in the field may limit this practice in the real world. 
In Section 5, I will address the methods used to disseminate and evaluate this project.  
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Section 5: Dissemination Plan 
Introduction 
An evidence-based research project is not complete without planning for the 
dissemination of information and knowledge acquired (Moran & Conrad,(2017). 
Knowledge transfer and the transformation of care using scientific knowledge can only 
be effective by disseminating information to the intended stakeholders (Moran & Conrad, 
2017) . In this section, I discuss my plans to disseminate the project. I also reflect on my 
growth as a project leader, practitioner, and scholar while completing my capstone.  
Plans for Dissemination 
Project findings may help motivate, educate, and inform the U.S. healthcare 
industry’s efforts to provide optimal care at minimal costs. The approach that was 
selected for the project’s dissemination was based on the method that best translates the 
information that was gained for the organization’s benefit to ensure it achieves the 
project’s stated goal. The approach aligned with recommendations by research that the 
method used to disseminate information should match the target audience (Gray et al., 
2014). Without proper dissemination, the home health agency may not fully realize their 
potential opportunity to provide high-quality patient care using evidence-based research. 
The inability to translate evidence into practice limits the nursing profession’s growth as 
an applied science profession. A professional construct of nursing notes that the 
translation of knowledge gained through research into evidence-based practice is 
necessary for the future growth of nursing as a profession (McEwen & Wills, 2015). The 
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professional construct of nursing posits that, for the nursing profession to be treated as a 
science, interventions performed on patients must be supported by research findings 
(McEwen & Wills, 2015).   
Dissemination of project findings may not only assist the home health agency in 
providing quality nursing care and improved outcomes but also be beneficial to patients, 
scholars, and manufacturers of intravenous immunoglobulin. The recent trend in 
healthcare demands that home health agencies—as an alternative to hospitals—use 
evidence-based practice in their provision of care (Reinke, 2012). When home health 
agencies implement evidence-based nursing care, they demonstrate to physicians and 
insurance companies that they can handle sophisticated nursing care and management 
related to IVIG. Researchers have noted that home health agencies must take an active 
role in preparing to lead the growing trend in healthcare cost control that is moving 
patients from acute settings to home health settings (see Reinke, 2012). The project 
supports home health agencies as equal partners in influencing change by using evidence-
based practice in care delivery.  
The approach to the project’s dissemination will comprise two levels: internal and 
external. At the internal level, I will disseminate within the home health agency as the 
primary focus; the main goal is to improve the system of operation by using a system of 
rapid response. Another focus at the internal level involves ensuring that the project is 
disseminated in such a manner that ensures its sustainability for the benefit of the 
organization as well as the patients it serves. Finally, the internal phase of the 
dissemination includes the formative and RE-AIM framework (Holtrop et al., n.d.) to 
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ensure reach, sustainability, implementation, adoption, and maintenance of the guideline. 
The meetings at each level should ensure the achievement of the goals of the evaluation 
as it is based on a process of adoption and implementation of the guideline as part of the 
agency policy and procedure and subsequent inclusion in the patient plan of care as 
required by laws governing home health agencies. The external dissemination method 
will be performed at the community and public levels to make acquired information 
available to other home health agencies and scholars to ensure transferability.  
Internal method of dissemination to the organization. The initial approach to 
the project’s dissemination involves having the agency’s administrator hold a meeting 
with the governing body, as is required by law, for the adoption of the clinical nursing 
guideline as part of their policy and procedure manual, as is required by the regulatory 
agencies. Having the guideline adopted clears the path for staff nursing education and 
allows the guideline to be implemented into the agency’s system of operation, which 
aligns with the overarching purpose of the project to improve quality of care. I will use 
the meeting to outline the steps needed for implementation as well as the staff’s general 
education. The meeting will provide an opportunity to discuss ways by which the 
company can ensure the project’s sustainability.  
After the expected adoption of the guideline by the governing body, I will present 
the project at the company’s professional action committee meeting in the form of a 
PowerPoint presentation. The professional action committee is a group of 
interprofessional specialists charged with overseeing the company’s clinical operation, as 
is required by the regulatory agencies. Presenting the information at this meeting will 
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ensure that the policy adopted by the agency is enforced and is made part of the agency’s 
guideline. I will use the meeting an opportunity to educate the committee on the benefits 
associated with guideline implementation and the importance of using evidence-based 
practice in patient care.  
The next step in the dissemination process is to schedule a meeting with the 
quality improvement officer at the agency. The purpose of this meeting is to plan how 
staff should be educated on the guideline and documentation that will form part of the 
company’s operational procedure. It is the responsibility of the quality improvement 
nurse to review nursing documentation, provide in-services to staff, and ensure 
compliance with the company’s policies. Part of the meeting will be focused on 
collaborating with the quality control nurse on staff in-services and placing the guideline 
on the company’s bulletin board. Staff nurses will be provided a forum wherein they may 
ask questions and seek clarification if necessary. I will ask members of the organization 
to place a laminated copy in the policy and procedure manual for future reference and to 
educate new nurses. 
External method of dissemination. I will perform various steps to disseminate 
the evidence-based project externally. The web is also another form of information 
dissemination. To leverage this medium, I will seek permission from the company to 
include the information online as part of their marketing skill strategy. 
Another approach to project dissemination will involve presenting the project at 
the yearly national forum of the Immunoglobulin National Society (IgNS). The IgNS is a 
national society that offers yearly meetings to discuss issues and innovation in the IG 
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living world (IgNS,2019). These meetings bring together various pharmaceuticals, 
physicians, researchers, and other allied healthcare professionals. For this reason, these 
meetings may potentially provide an opportunity to introduce the project to a group of 
interprofessional specialists and manufacturers. I will use this opportunity to present and 
discuss how my findings can be adopted as part of a uniform, gold standard for IVIG 
infusion. I will provide handouts at the meetings to encourage other home health agencies 
to implement the project in their respective organizations.  
In addition, I will use the Walden University dissertation forum to publish the 
project as an article. This venue makes the article available to scholars and others who 
may continue referring to it to advance their knowledge. My ultimate goal is to submit 
the manuscript to a nursing journal for publication. The publication of the research 
outcome and findings should provide nurses with the knowledge and evidence required to 
provide quality care to patients. Publishing the project will also allow other clinicians and 
researchers to apply project findings in other contexts. 
Analysis of Self 
The journey toward obtaining my DNP degree has been a difficult although 
worthwhile adventure. My ability to prevail over obstacles, both internal and external, 
has been instrumental to the completion of the program. The knowledge I have gained by 
reviewing the degree program’s essentials offers a positive, professional, and leadership 
interaction with patients, the community, and the practice itself.  
As a determined, goal-driven person who is filled with curiosity and the will to 
learn, it is becoming increasingly necessary that I use my acquired scholarship when 
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venturing into entrepreneurship to act as a patient advocate, promote public health, 
improve the organizational system, and improve advanced practice nursing care’s 
management of the chronic disease.  
Venturing into the business will create the opportunity to provide underserved 
communities access to healthcare. The United States, as a developed country, cannot 
boast that it's suffering citizens possess quick access to care. The obtained scholarship 
facilitates the introduction of programs that seek to benefit weak individuals within the 
community. This scholarship has comprehensively helped me cultivate the leadership 
skill necessary to contribute toward change by influencing policies. Nurse leaders are 
needed to educate the future nursing workforce, and the scholarship received through 
Walden University is instrumental in participating in leadership. 
Project Leader 
 As a clinical nurse manager, the knowledge I have gained through my DNP 
project has been instrumental in helping me focus more closely on the importance of 
using evidence-based knowledge when providing care. Part of my leadership contribution 
of promoting the translation of evidence into practice involves using the knowledge I 
gained through this scholarship, the best method for education nursing staff by using 
scientific research articles.  
We have enacted policies wherein the use of evidence-based practice in task 
performance encourages nurses to seek higher education. My educational exposure has 
allowed that I support the use of the evidence-based nursing practice in the workplace. 
An aspect of leading the future generation of nurses involves the incorporation of an in-
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service plan that implements evidence-based articles and guidelines to educate nurses. In-
services are planned using research articles and new recommendations specific to patient 
management. I additionally implemented a patient education method that utilizes 
evidence-based practice rooted in research findings; such utilization not only educates 
patients on disease processes and medications ordered but also offers reasons for the 
adoption of interventions and their expected outcomes as well as possible side effects that 
must be considered when managing those interventions. Moreover, we have implemented 
policies that seek to answer questions using the theoretical basis of nursing to promote 
our profession’s growth. 
Practitioner 
 Advancing nursing practice is a significant part of the DNP Essentials (AACN, 
2011). Nurses should take active roles when leading change through knowledge 
embedded in education (AACN, DNP Essentials, 2011). As nurses, we must gain 
advanced knowledge of disease pathophysiology and management to benefit the 
community. Part of advancing nurse practice leadership requires the use of scholarship 
underpinning for patient care (AACN, 2011). Education and training are a major part of 
leadership training. The IOM report charges nurses to gain leadership through education 
and training to equip them with the tools necessary to train the future generation of nurses 
(IOM, 2010).  
The developed leadership is based on education that supports the profession’s 
growth and improves the quality of care patients receive within the healthcare 
community. Nurses comprise more than one-third of the healthcare employee population 
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and should, therefore, be at the forefront of influencing healthcare policies through active 
participation.  
Advancing the goals outlined in the essentials was an important influence within 
the practicum setting. During the practicum, I took advantage of the diversity within the 
setting to gain systems knowledge and use interprofessional collaboration to manage the 
disease process. Part of the advancing nursing practice was also centered on obtaining the 
education needed for the development of public health policies. Based on the acquired 
education, I implemented a system wherein interprofessional collaboration may be used 
to manage chronic disease processes: systems management and the use of 
interprofessional communication in improving.  
I introduced the system of medication reconciliations between pharmacies, 
patients, and the practice upon discharge of patients from acute care setting or visits to 
specialists to decrease fragmentation in care and improve a line of interprofessional 
communication. In addressing chronic disease management, I developed forms and a 
policy that relies on evidence-based research to assess patients upon their arrival at a 
clinic as well as symptoms management about hypertension, high cholesterol, autism, 
vaccination, and diabetes mellitus. I also took advantage of my newly acquired 
knowledge to develop a system that ensured compliance with the use of informatics for 
managing population health and ensured the practices were following Merit-based 
Incentive Payment System (MIPS) as detailed by Center for Medicare (CMS,2018).  
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Scholar 
The nursing scholarship is the acquisition of knowledge that informs and arms 
future leaders with the information necessary to manage the growing diversity in the 
healthcare industry. An important purpose for the development of Advanced nursing 
education is the production of future leaders that can translate research evidence into 
practice promptly (Moran et. al.2017).  We are currently amidst an era of increased 
diversity in the healthcare industry, which requires that management staff be prepared to 
handle the ever-increasing complications and regulations occurring within the industry. 
In an era of educated patients who seek answers to problems that are supported by 
research, we must utilize scholarship to provide answers and solutions to their problems. 
The DNP education provided the vehicle for my knowledge acquisition; part of the DNP 
essentials involves preparing nurses to use education to influence healthcare decisions 
and improve the quality of their provision of care. The scholarship also serves to educate 
the community about how they may seek health promotion and disease prevention.  
Part of my nursing scholarship has been centered on improving my personal 
growth, and Walden University has been instrumentally helpful as I prepare for my 
professional growth. Walden University developed an outline that matched the 
recommendations outlined in the DNP essentials for knowledge required in advanced 
nurse practitioners (AACN, 2011).  The classroom participation experience I gained 
alongside the practicum’s learning activities satisfied the goals I needed to achieve for the 
learning process to occur. This information was acquired with the essentials of the DNP 
requirements to ensure that the scholarship’s objective and goals were met.  
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As a nurse leader, I am better able to inform the decisions I make in the workplace 
using evidence-based research articles and putting such evidence into practice through 
communication. Also, through the information I have gained through the scholarship, I 
have been able to influence policies centered on evidence-based practice. The DNP 
project informed me about the research process, the methods used to analyze and 
synthesize articles, the importance of rigors, and the steps that must be taken along the 
research process.  
  
Challenges in Completing the Project 
 While embarking on a scholastic journey to find answers that fill knowledge gaps 
where such gaps exist may prove to be a daunting task, implementing and disseminating 
research findings can be equally challenging. Overcoming this challenge requires 
preparation, risk calculation, and methods for solving issues as they arise. Part of this 
challenge lies in the financial resource availability for training nurses on how to use new 
knowledge, while another challenge involves finding the most suitable method of 
information transfer and sustainability. The process of communicating research findings 
presents a significant challenge in preparing the project. Some of the information to be 
processed is deciding the best method to be used, who are the stakeholders, where are the 
resources for the training coming from, and the sustainability of the project.   I used the 
organization chart to learn about the internal flow of information, and this informed the 
way I planned my information sharing.  
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 To discover solutions to these challenges, I researched methods used by other 
scholars and noted what worked for them, what made them fail and why these results 
were achieved. Tackling these challenges allowed that I batch the problems and create a 
dissemination method that addressed both internal and external factors. That the home 
health agency can utilize immediately in implementing evidence-based practice,  
Another challenge is navigating the external factors that can impair the project 
implementation within the home health organization. The most important external factor 
is federal and state regulations that the home health agency must comply with if they are 
to keep their operational licensure. Compliance issues in the area of medications that are 
allowed to be administered in the home setting were tracked, studied, and noted. It was 
also important to ensure that the method used in dissemination follows the 
recommendation of the regulatory agencies in the area of policy adoption, staff education, 
and professional action committee approval. In tackling the challenges presented required 
reading the rules and regulations that guide home health agencies both at the local and 
federal level,  
The DNP student is trained as a leader in influencing change. Part of that 
leadership skill requires communicating with other leaders to use interprofessional 
collaboration in patient care. The project presented a challenge as I had to communicate 
with leaders from the varied discipline of the importance of interprofessional 
collaboration in bringing about a positive patient outcome. Meetings and conferences 
offered an opportunity needed to overcome the challenge that fragmentation in 
professional skills has created in the health care industry.  
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Intuition Gained 
Selecting the DNP project and knowledge gap to be addressed presented a 
significant challenge. It was important in the early decision making to determine the best 
approach that will present a significant positive outcome. It was important in the early 
process of the project writing to plan the focus question and abstract in such a way to 
avoid receiving a rejection of the project by the school committee chair.  To overcome 
the obstacle, I utilized the Walden guidelines on the project writing process, type of 
projects that are accepted, and project checklist as a tool that informs the project. 
 Another intuition is in is selecting the method for information sharing for the 
sustainability of the project. Research projects to be useful must be translated into 
practice. Part of dissemination lies in the ability of the DNP student as a leader to share 
knowledge gained with other leaders to improve patient outcome.   
Future Career Growth 
Tremendous educational enrichment has been gained as a result of my DNP 
education. I can more effectively influence and support changes using my evidence-based 
project and the theoretical basis of nursing, respectively. The team of nurses with whom I 
work will now view themselves as champions for change within the organization.  
 As I continue to grow, I foresee a future in nursing entrepreneurship; owning a 
business that addresses the community’s need will be an essential part of the training I 
obtained through the program. 
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Summary 
This project’s dissemination is a significant aspect of the Doctor of the nursing 
degree process. Without information transfer, search effort is wasted.  This evidence-
based research is important in proving that home health agencies as part of the health care 
community can effectively provide quality care in the patient environment that is based 
on a nursing practice that utilizes scientific evidence as a basic unit for the provision of 
quality health care.  The project used the nursing theory and frameworks to support the 
evidence. Several frameworks and theories gave evidence that supports the theoretical 
framework of nursing as a profession.  Part of the decision regarding the utilized method 
involved reviewing the organization to ensure that certain decisions considered the 
system of operation and the project’s purpose. I additionally took advantage of the project 
to analyze my future goals and determine how to achieve them. 
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Appendix A: Rapid Response Standing Orders 
 
Mild Symptom 
 Initial intervention  
1. Hydrate with normal saline 250ml Intravenous piggy back  
2. may repeat premeds of Benadryl and Tylenol 
3. Start with the lowest possible dose and increase as needed per standing 
order protocol 
Symptoms Rapid Response 
Medications 
Outcome/document dose 
given 
Nausea Zofran 4mg IVP q4-6hrs 
PRN 
Phenergan 12.5-25mg 
IVPB q6hrs 
Reglan 10mg SIVP q6hrs- 
monitor for tardive 
dyskinesia 
 
Flushing 
 
 
 
Tylenol 1000 mg  PO  
 Q6 hrs PRN 
Benadryl 25 mg to 50 mg 
PO, PRN do not exceed 100  
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Symptom 
Mild Reaction  
continued 
Rapid Response 
Medications  
continued 
 
Outcome / Document dose 
given 
 
 Mg in 24 hours   
Spasms Valium- 2.5 to 10 mg SIVP 
4 to 6 hrs prn intravenous 
 
Restless legs Valium -5 mg to 10 mg 
SIVP intravenous  
Lorazepam- 0.2 mg to 1 mg 
SIVP X1 intravenous 
 
Mild Headaches Anti-inflammatory e.g. \ 
Slow rate of infusion, to 
tolerable rate if no relief, 
Repeat Tylenol and 
Benadryl premeds if no 
relief then  
Toradol 30mg IVP Q4 TO 
6HRS PRN 
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Moderate 
Slow or stop the infusion until rapid response medications are given 
Start normal saline 250ml IVPB 
Restart infusion of IVIG at a lower rate when symptoms resolve 
 
 
Symptoms Rapid Response 
Medications IVP 
Outcome / 
Document dose given 
 
Nausea with Vomiting Zofran 4mg IVP Q4HRS 
PRN 
Normal Saline 250ml IVPB 
 
Migraine/full headache Depakote, 500mg IVPB 
Decadron 10mg SIVP or 
Solumedrol 40 MG, 100 
MG,  to 125 mg IVP 
May increase to 250 mg if 
not diabetic 
 
Elevated Blood Pressure Consider Clonidine 0.1 mg 
for pts with hypertension 
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Symptoms  Rapid Response 
Medications IVP 
 
Outcome / 
Document dose given 
 
Chills  Low dose Valium 2.5 mg to  
10 mg SIVP in graduated 
dosing. Monitor sedation 
 
 
Severe Flushing Benadryl intravenous, stop 
the infusion and resume at a 
low rate 
 
Normal Saline Hydration 250 ml bolus pre or post 
infusion 
 
Decrease Infusion rate Patient tolerance  
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Severe 
Start Normal saline hydration 
Stop infusion for 3o minutes, activate intervention and restart at a low rate of infusion 
Vomiting with or without 
nausea 
Intravenous Anti-emetic such 
as Zofran, Phenergan 
 
Nuchal rigidity 
 
 
 
Symptoms 
Stop infusion, start normal 
saline hydration,  
medicate with  
 Benadryl 50mg IVP 
Rapid Response 
Medications- IVP 
 
 
Notify Md 
 
 
 
Outcome / Document dose 
given 
 
Nuchal Rigidity Intravenous antiemetic 
Zofran 4mg IVP 
 Or  
Stay until patient stable 
 
Elevated blood pressure Anti-hypertensive if reducing 
and aborting infusion does not 
control blood pressure 
 
Back pain 
 Mild to severe 
Normal saline 250 ml bolus 
Toradol 30mg SIVP 
Educate pt on oral hyd- 
Notify MD, Pharmacist/ 
Clinical Nurse Manager  
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ration 
Monitor voiding 
Back pain 
 
Educate pt on oral hydration 
Monitor pt for adequate 
voiding--possible acute renal 
failure  
 
Chest pain 
 
 
Symptoms 
Stop infusion 
Monitor and activate EMS 
if  needed 
Rapid Response 
Medications- IVP 
 
 
 
 
 
Outcome / 
Document dose given 
 
Hives  ❖ Stop infusion  
❖ Monitor Pt for 
increasing reaction  
❖ If  reaction is not 
progressing but still 
present, Consider 
activating 
anaphylactic protocol  
of Epi-Pen,   
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❖ Start hydration with 
normal saline IVPB 
❖ Give  Intravenous 
Benadryl 25 to 50 mg  
per protocol 
❖ Notification call to 
MD and Supervising 
Nurse for further 
direction. 
   
 
Sources for Epi-Pen- protocol in the home setting: 
❖ Guidelines for Administration of Intravenous Immune ...Epinephrine 
should be available in the treatment area retrieved from  
https://www.health.gov.nl.ca/health/bloodservices/pdf/guidelines_admin_ivig.pdf 
 
❖ Title: Immune Globulin Intravenous(IVIG). Have epinephrine readily 
available. Retrieved from  
https://www.utoledo.edu/policies/utmc/nursing/guidelines/general/pdfs/immu
ne_globulin... 
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 Wang,S.,Lara,P., Lee-0w,A.Reed.,J.,& Wang.,A.(2002). Acetaminophen and 
diphenhydramine as premedication for blood product transfusions:Aprospective 
randomized double-blind placebo-controlled trial. American Journal of 
Hematology. 70(3). Retreived from  https://doi.org/10.1002/ajh.10119  
  
 
 
Nursing consideration 
1.  Educate pt. on hydration prior to infusion 
2. Make sure standing order signed before implementing patient care 
3. Coordinate with specialty pharmacy before initiating care to ensure insurance    
approval and delivery of essential drugs in the patient’s home.  
4. Call pt. to ensure medication delivered and rapid response medications available. 
5. Premedicate patient before next infusion as signed 
84 
 
Appendix B: Levels of Evidence 
 
Figure B1, Levels of evidence for the project. The total number of evidence-based 
articles reviewed after exclusion criteria was 35. The total selected that focused on the 
study was 12. 
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level of evidence
 
 
Figure B2. Pie chart showing the levels of evidence for the project. 
